Medical education research remains the poor relation

The requirement that clinical practice should be based on the best available evidence has been paralleled by calls for medical education to become more evidence based.1-3 This has resulted, among other initiatives, in the establishment of the Best Evidence for Medical Education (BEME) Collaboration4 and the Campbell Collaboration, an off-shoot of the Cochrane Collaboration. The BEME initiative includes dissemination of best evidence to support medical education and the encouragement of a culture capable of nurturing more rigorous and better funded research

AN EXAMINATION OF THE INDICATORS OF EFFECTIVE COLLABORATION IN TREATMENT OF LANGUAGE DISORDERS IN CHILDREN WITH AUTISM IN NAIROBI CITY, KENYA

The purpose of this study was to examine the indicators of effective collaboration in the treatment of language disorders in children with autism in Nairobi City County. This study was guided by Belbin’s Theory of Teamwork and Gregory’s Theory of Perception. The study adopted the qualitative research design targeting 55 caregivers and 10 speech therapists. Purposive sampling was used to select 20 participants. The research was conducted in Nairobi County and piloting at a medical Hospital. Qualitative data was collected using in-depth interviews and analysed thematically. The study findings showed that the indicators of effective collaborative approaches include achievement of set goals, improved speech, inclusivity of all those involved, improved sharing of information, and improved decision-making. Collaboration ensures that the caregivers are well-informed about the treatments and interventions. The study recommends that the public should be educated on the different disorders such as autism and other spectrum disorders that may cause language disorders to address issues of stigmatization and the benefits that come with adopting collaborative approaches in treating language disorders in children with autism.  Article visualizations

Patient Counseling for Finerenone

Finerenone is a nonsteroidal mineralocorticoid receptor antagonist, which is used to retard the progression of chronic kidney disease in persons with type 2 diabetes. This communication describes the various aspects of patient counseling needed to ensure safe and effective usage of the molecule. It utilizes the 5C checklist: Confirmation of clinical indication; Caveats and contraindications; Concerns and checkpoints; Caution and use with concomitant medication; and Constraints and cost, to create a simple, yet comprehensive tool for clinical use

Introduction

This special issue of Études irlandaises is dedicated to the arts. It deliberately privileges conversations with artists and practitioners, and aims at giving readers an insight into current artistic practices in Ireland with an emphasis on new technological, conceptual or political contexts. Before delving into the questions raised in the volume, we would like to extend our warmest thanks to the contributors and to the artists for generously accepting to answer our questions: their unwaverin..

Creating value through real-time knowledge generation: Improvisation and organisational learning in new product development [Abstract]

Creating value through real-time knowledge generation: Improvisation and organisational learning in new product development [Abstract

Longitudinal changes in moderate-to-vigorous-intensity physical activity in children and adolescents: a systematic review and meta-analysis

Moderate‐to‐vigorous‐intensity physical activity (MVPA) is important for childhood obesity prevention and treatment, yet declines with age. Timing and magnitude of the decline in MVPA in children and adolescents are unclear but important for informing effective obesity intervention development. This systematic review aimed to determine and compare the year‐to‐year changes in MVPA among children and adolescents. Longitudinal studies were identified by searching 10 relevant databases up to December 2018. Studies were eligible for inclusion if they reported accelerometer‐assessed MVPA (min day−1) separately for boys and girls and had follow‐up duration of at least 1 year. After screening 9,232 studies, 52 were included representing 22,091 aged 3 to 18 year olds (boys=8,857; girls=13,234). Pooled‐analysis of the relative change in MVPA per year showed a decline of −3.4% (95% CI, −5.9 to −0.9) in boys and −5.3% (95% CI, −7.6 to −3.1) in girls, across all age groups. There were notable declines in MVPA at age 9 for both boys (−7.8%, 95% CI, −11.2 to −4.4) and girls (−10.2%, 95% CI, −14.2 to −6.3). The relative decline in MVPA affects both sexes from an early age; however, it is greater among girls. Interventions to promote MVPA should start before adolescence